Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics Inc.
WKN: A3DS0P / Symbol: SLNO / Name: Soleno Therapeutics / Aktie / Micro Cap /
35,66 €
-0,56 %
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $123.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $106.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) was given a new $125.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
Ratings data for SLNO provided by MarketBeat
Neueste Beiträge
Lucid_Cap_Mkts in Golub Capital Bdc Inc. diskutieren